Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: A meta-analysis with trial sequential analysis of randomized controlled trials

Clinical Nutrition

Volumn 37, Issue 2, 2018, Pages 505-515

  Wu, Xiang Dong ^a   Liu, Meng Meng ^b   Liang, Xi ^a   Hu, Ning ^a   Huang, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Prebiotics; Probiotics; Surgery; Synbiotics

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL OUTCOME; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEFECATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; PERIOPERATIVE PERIOD; PNEUMONIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEPSIS; SEQUENTIAL ANALYSIS; SUPPLEMENTATION; SURGICAL INFECTION; SURGICAL PATIENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION; COST BENEFIT ANALYSIS; DIETARY SUPPLEMENT; ECONOMICS; INFECTION CONTROL; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGERY;

COST-BENEFIT ANALYSIS; DIETARY SUPPLEMENTS; HUMANS; INFECTION CONTROL; LENGTH OF STAY; PERIOPERATIVE CARE; PROBIOTICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, OPERATIVE; SYNBIOTICS; TREATMENT OUTCOME;

EID: 85042861435     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.10.015     Document Type: Article

References (47)

1. Weiser, T.G., Regenbogen, S.E., Thompson, K.D., Haynes, A.B., Lipsitz, S.R., Berry, W.R., et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372 (2008), 139–144.
2. Prevention and Treatment of Surgical Site Infection. NICE Clinical Guidelines, No. 74. National Collaborating Centre for Women's and Children's Health (UK). Available from: http://www.nice.org.uk/guidance/cg74 [Accessed 31 July 2016].
3. Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C.K., et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 173 (2013), 2039–2046.
4. Kurz, A., Sessler, D.I., Lenhardt, R., Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334 (1996), 1209–1215.
5. Klevens, R.M., Edwards, J.R., Richards, C.L. Jr., Horan, T.C., Gaynes, R.P., Pollock, D.A., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122 (2007), 160–166.
6. Rijkers, G.T., de Vos, W.M., Brummer, R.J., Morelli, L., Corthier, G., Marteau, P., Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr 106 (2011), 1291–1296.
7. de Vrese, M., Schrezenmeir, J., Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111 (2008), 1–66.
8. Barraud, D., Bollaert, P.E., Gibot, S., Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest 143 (2013), 646–655.
9. Deshpande, G., Rao, S., Patole, S., Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 369 (2007), 1614–1620.
10. Johnston, B.C., Ma, S.S., Goldenberg, J.Z., Thorlund, K., Vandvik, P.O., Loeb, M., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 157 (2012), 878–888.
11. Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N., Shanman, R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307 (2012), 1959–1969.
12. Pitsouni, E., Alexiou, V., Saridakis, V., Peppas, G., Falagas, M.E., Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 65 (2009), 561–570.
13. He, D., Wang, H.Y., Feng, J.Y., Zhang, M.M., Zhou, Y., Wu, X.T., Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: a meta-analysis of randomized controlled trials. Clin Res Hepatol Gastroenterol 37 (2013), 406–415.
14. Kinross, J.M., Markar, S., Karthikesalingam, A., Chow, A., Penney, N., Silk, D., et al. A meta-analysis of probiotic and synbiotic use in elective surgery: does nutrition modulation of the gut microbiome improve clinical outcome?. J Parenter Enter Nutr 37 (2013), 243–253.
15. Sawas, T., Al Halabi, S., Hernaez, R., Carey, W.D., Cho, W.K., Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 13 (2015), 1567–1574 e3; quiz e143–4.
16. Lytvyn, L., Quach, K., Banfield, L., Johnston, B.C., Mertz, D., Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials. J Hosp Infect 15 (2015), 00384–00389 pii: S0195-6701.
17. References 17–50 can be found in Data S1. Additional reference of randomized controlled trials included in the meta-analysis.
18. Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. Available from: http://www.cochrane.org/handbook [Accessed 31 July 2016].
19. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8 (2010), 336–341.
20. Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
21. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
22. Schünemann, H., Brozek, J., Guyatt, G., GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.6. 2011, McMaster University, GRADE Working Group, Hamilton, Ontario, Canada Available from: http://ims.cochrane.org/revman/gradepro [accessed 31 July 2016].
23. Hozo, S.P., Djulbegovic, B., Hozo, I., Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol, 5, 2005, 13.
24. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
25. Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
26. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
27. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C., Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61 (2008), 64–75.
28. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C., Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol, 9, 2009, 86.
29. Thorlund, K., Devereaux, P.J., Wetterslev, J., Guyatt, G., Ioannidis, J.P., Thabane, L., et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. Int J Epidemiol 38 (2009), 276–286.
30. Thorlund, K., Imberger, G., Walsh, M., Chu, R., Gluud, C., Wetterslev, J., et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis–a simulation study. PLoS One, 6, 2011, e25491.
31. User Manual for Trial Sequential Analysis (TSA) from the Copenhagen Trial Unit. Center for clinical intervention research, Rigshospitalet, Copenhagen, Denmark. Available from: http://www.ctu.dk/tsa/ [Accessed 31 July 2016].
32. Cosgrove, S.E., The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42:Suppl 2 (2006), S82–S89.
33. Arias, C.A., Murray, B.E., Antibiotic-resistant bugs in the 21st century–a clinical super-challenge. N Engl J Med 360 (2009), 439–443.
34. Chouraqui, J.P., Grathwohl, D., Labaune, J.M., Hascoet, J.M., de Montgolfier, I., Leclaire, M., et al. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr 87 (2008), 1365–1373.
35. Tapiovaara, L., Lehtoranta, L., Poussa, T., Mäkivuokko, H., Korpela, R., Pitkäranta, A., Absence of adverse events in healthy individuals using probiotics-analysis of six randomised studies by one study group. Benef Microbes 7 (2016), 161–169.
36. Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J.N., Suttorp, M.J., et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess Full Rep 200 (2011 Apr), 1–645.
37. Gu, W.J., Deng, T., Gong, Y.Z., Jing, R., Liu, J.C., The effects of probiotics in early enteral nutrition on the outcomes of trauma: a meta-analysis of randomized controlled trials. J Parenter Enter Nutr 37 (2013), 310–317.
38. Dhiman, R.K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K.K., et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology, 147, 2014 1327–37.e3.
39. Whelan, K., Editorial: the importance of systematic reviews and meta-analyses of probiotics and prebiotics. Am J Gastroenterol 109 (2014), 1563–1565.
40. McKenney, P.T., Pamer, E.G., From hype to hope: the gut microbiota in enteric infectious disease. Cell 163 (2015), 1326–1332.
41. Subramanian, S., Blanton, L.V., Frese, S.A., Charbonneau, M., Mills, D.A., Gordon, J.I., Cultivating healthy growth and nutrition through the gut microbiota. Cell 161 (2015), 36–48.
42. Chu, H., Mazmanian, S.K., Winning the microbial battle, but not the war. Cell 163 (2015), 271–272.
43. Klaenhammer, T.R., Kleerebezem, M., Kopp, M.V., Rescigno, M., The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol 12 (2012), 728–734.
44. Bratzler, D.W., Dellinger, E.P., Olsen, K.M., Perl, T.M., Auwaerter, P.G., Bolon, M.K., et al. American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70 (2013), 195–283.
45. Surgical Site Infection Prevention and Treatment of Surgical Site Infection, NICE clinical guidelines, No. 74. National Collaborating Centre for Women's and Children's Health (UK). 2008 Oct, RCOG Press, London.
46. Anderson, D.J., Podgorny, K., Berríos-Torres, S.I., Bratzler, D.W., Dellinger, E.P., Greene, L., et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35 (2014), 605–627.
47. Diaz, V., Newman, J., Surgical site infection and prevention guidelines: a primer for certified registered nurse anesthetists. AANA J 83 (2015), 63–68.